Anúncio
Anúncio
SNSE
Sensei Biotherapeutics, Inc. Common Stock
11.66
USDPatrocinado
+0.60
+5.42%
09 de jan., 15:57 UTC -5
Encerrado
Pós-Mercado
11.09
-0.57
-4.89%
Relatórios de Lucros SNSE
Rácio de surpresa positiva
SNSE separação 12 de 20 últimas estimativas.
60%
Próximo Relatório
Data do Próximo Relatório
26 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$4.90
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/+35.36%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-20.97%
Sensei Biotherapeutics, Inc. Common Stock earnings per share and revenue
On 14 de nov. de 2025, SNSE reported earnings of -3.62 USD per share (EPS) for Q3 25, beating the estimate of -4.19 USD, resulting in a 13.65% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -11.25% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -4.90 USD, with revenue projected to reach -- USD, implying an aumentar of 35.36% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Sensei Biotherapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Sensei Biotherapeutics, Inc. Common Stock reported EPS of -$3.62, beating estimates by 13.65%, and revenue of $0.00, 0% as expectations.
How did the market react to Sensei Biotherapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -11.25%, changed from $9.02 before the earnings release to $8.01 the day after.
When is Sensei Biotherapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 26 de mar. de 2026.
What are the forecasts for Sensei Biotherapeutics, Inc. Common Stock's next earnings report?
Based on 3
analistas, Sensei Biotherapeutics, Inc. Common Stock is expected to report EPS of -$4.90 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio